
bioRN News

Menarini Biotech (MBH) is a leading CDMO specializing in Process Development and GMP manufacturing across various therapeutic areas. With a mission to be a reliable, agile, and innovative partner, MBH empowers its customers to bring life-saving biotherapeutics to patients through expertise in drug development. From lab to production, cutting-edge technology accelerates processes, optimizes yields, and […]
read more
New Member: Welcome in our cluster to GeneTechX
At GeneTechX, they are developing a nutrigenomics platform that combines genetics and nutritional science to create personalized dietary solutions. Leveraging advanced gene-editing technologies like PrimeCRISPR, they investigate the intricate relationships between genes, diet, and health outcomes. By identifying genetic variations that affect nutrient metabolism, GeneTechX delivers tailored nutrition strategies to enhance health and prevent disease, […]
read more
New Member: Welcome in our cluster to Akribion Therapeutics GmbH
Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Its G-dase® E nuclease has the ability to kill cells by shredding DNA and RNA, but only if there is a highly specific match between the guide RNA and an intracellular RNA sequence. This ensures that only the targeted cells are affected, […]
read more
New Member: Welcome in our cluster to Alcedis GmbH
Alcedis is a globally operating, leading full-service CRO with over 30 years of experience in clinical research. As a member of the Huma Group, they combine deep expertise with innovative AI-driven technologies to conduct clinical trials efficiently and accurately – from Phase I to market authorization, medical device projects, and real-world evidence. Their in-house competence […]
read more
New Member: Welcome in our cluster to Myotwin GmbH
At Myotwin, the vision is to revolutionize drug development through innovation and compassion. The team is creating a digital twin of the human heart muscle, built from extensive high-content datasets, to enable animal-free drug testing. This groundbreaking platform aims to reshape pharmaceutical research by offering ethical, precise, and effective drug testing methods. By leveraging technology […]
read more
New Member: Welcome in our cluster to Cell Signaling Technology Europe B.V.
Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools to the biomedical research community. CST empowers scientists worldwide with innovative, high-quality tools to advance discovery. Beyond science, CST prioritizes responsibility by partnering with communities and minimizing environmental impact. As the first life science member of […]
read more
New Member: Welcome in our cluster to BioKryo GmbH
BioKryo is a biorepository focused on the storage of biological samples in temperatures ranging from -196°C in liquid nitrogen in cryotanks to -80°C, -20°C and 4°C in freezers. Their goal is to support biotechnology/pharmaceutical companies in their manufacturing process by providing a safe, redundant and qualified storage of their biological samples. Some examples of samples […]
read more
New Member: Welcome in our cluster to Pitchload GmbH
Pitchload’s goal is to make innovation ecosystems more transparent, accessible, and efficient. Startups and accelerators currently waste time maintaining databases and creating PDFs. Pitchload’s mission is to create a “single source of truth” for the European innovation ecosystem, starting locally but aiming globally. Pitchload offers streamlined information sharing, syncing with third-party systems, and privacy control […]
read more
New Member: Welcome in our cluster to iQMedix GmbH
iQMedix aims to improve the lives of cancer patients by providing personalized treatments based on molecular analysis. Using liquid biopsies to determine gene expression profiles from circulating tumor cells, iQMedix enables doctors to tailor therapies to each patient’s unique cancer. Their approach offers precise insights to determine effective treatments. Their vision is to make cancer […]
read more